Octapharma AG
Octapharma AG is a Biotech company based in Lachen (Schwyz) recorded by Swissmedic as the authorisation holder for 12 human medicines. That places it 128 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Blutprodukte.
Key facts
| Sector | Biotech |
|---|---|
| City | Lachen |
| Canton | Schwyz |
| Authorisation holder | Yes |
| Medicines | 12 |
| Founded | 1983 |
| Employees | 201-1000 |
| Parent group | Octapharma AG (Group) |
| Activity | Not available |
| Website | octapharma.ch |
Medicines authorised in Switzerland
Octapharma AG is recorded by Swissmedic as the authorisation holder for 12 human medicines. The table shows 12 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
12 of 12 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Albunorm 5 % | 62660 | B | B05AA01 | 2012-09-27 |
| Atenativ 500 I.E. | 47604 | B | B01AB02 | 1988-03-30 |
| Cutaquig 165 mg/ml | 68222 | B | J06BA01 | 2022-02-15 |
| Fibryga 1g | 66836 | B | B02BB01 | 2018-11-22 |
| Nuwiq 250 IE | 65551 | B | B02BD02 | 2016-05-26 |
| Octagam 10 % | 60323 | B | J06BA02 | 2010-02-16 |
| Octanate 250 I.E. | 666 | B | B02BD02 | 2003-09-02 |
| octaplasLG | 602 | B | B05AA | 1999-04-20 |
| octaplasLG | 69780 | B | B05AA | 2024-11-12 |
| Octaplex 500 | 57918 | B | B02BD01 | 2006-08-16 |
| Panzyga 100 mg/ml | 70202 | B | - | 2026-05-08 |
| Wilate 500 I.E. | 56133 | B | B02BD06 | 2006-06-07 |
Frequently asked questions
How many medicines does Octapharma AG have authorised in Switzerland?
Octapharma AG is recorded by Swissmedic as the authorisation holder for 12 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Octapharma AG based?
The Swiss location recorded for Octapharma AG is Lachen, Schwyz.
Is Octapharma AG a Swissmedic authorisation holder?
Yes. Octapharma AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.